Get informed when a big investor buys or sells
+ FollowOvervalued by 111.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $509,286.00 |
|---|---|
| Enterprise Value | $646,071.00 |
| Earnings per Share | $-0.01 |
| Beta | -1.05 |
| Outstanding Shares | 25,464,279 |
| P/E Ratio | -2.63 |
|---|---|
| PEG | 15.74 |
| Price to Sales | - |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.7 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | -0.26 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Tanke Biosciences Corporation (TNBI) is a company dedicated to the development, production, and sale of a diverse portfolio of animal nutrition and feed additive products through its various subsidiaries. The company organizes its busine...